Blum Robert I sold CYTK
September 15, 2026 · Form 4 insider transaction
Blum Robert I sold 97,926 shares of Cytokinetics, Incorporated at $69.33 per share, a transaction worth $6.79M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
97,926
Price
$69.33
Total value
$6.79M
InsiderBlum Robert I
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 15, 2026
Filing dateSeptember 15, 2026
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Sale of shares of common stock by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares sold or the proceeds thereof.